We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
NovaTec Immundiagnostica GmbH

Nova Biomedical

  Gold Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer

By LabMedica International staff writers
Posted on 19 Nov 2020
Print article
Image: Nova Primary analyzer (Photo courtesy of Nova Biomedical)
Image: Nova Primary analyzer (Photo courtesy of Nova Biomedical)
Nova Biomedical (Waltham, MA, USA) has launched Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer that fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer from YSI, Inc., (Yellow Springs, OH, USA).

Manufacturers of blood glucose measuring devices and clinical diabetes researchers have relied on the YSI 2300 as a reference and correlation analyzer. However, as of July 2021, YSI, Inc. is no longer supporting the analyzer, and its discontinuation has left a critical industry void. The Nova Primary analyzer fills that need and will be available for sale in CE regulated countries from January 2021. The Nova Primary was also submitted to the US Food and Drug Administration (FDA) for 510(k) clearance in November 2020 and is anticipated to receive clearance in the first half of 2021.

Similar to the YSI 2300, Nova Primary uses a single, reusable glucose electrochemical sensor based on glucose oxidase and has a measurement range of 10-900 mg/dL. It uses a small, 25 microliter venous whole blood or plasma sample which is internally diluted like the YSI. Results are available in approximately two minutes. Nova Primary’s large color touchscreen display and intuitive, icon-based graphical user interface make it very straightforward to use. A single calibrator pack uses RFID data management to monitor the pack expiration date and number of samples remaining, eliminating the need for separate reagent bottles and daily monitoring of their levels. In clinical laboratory studies using venous whole blood and plasma Nova Primary demonstrated excellent correlation to the YSI 2300 and is traceable to NIST glucose standards.



Print article

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.